Capex has been selected to participate in Global Hypergrowth Tokyo 2024, a prestigious 10-month scaling program developed by Startup Genome and the Tokyo Metropolitan Government.The program supports 22 leading Tokyo-based tech companies in accelerating their international expansion through world-class mentorship, strategic advisory services, and access to global networks of investors and business partners.
Global Hypergrowth Tokyo is part of Startup Genome’s proven track record of supporting late-stage startups worldwide. Previous program participants have achieved significant milestones, including companies that doubled their revenue during participation.Through this program, Capex aims to accelerate its global expansion strategy and establish a stronger presence in international markets.
Learn more about the program: Global Hypergrowth Tokyo Announcement